This is a preview of subscription content, log in via an institution to check access.
Notes
2011 British pounds
Reference
McIntosh E, et al. Cost-Effectiveness of Dopamine Agonists and Monoamine Oxidase B Inhibitors in Early Parkinson's Disease Movement Disorders : 7 May 2021. Available from: URL: https://doi.org/10.1002/mds.28623
Rights and permissions
About this article
Cite this article
Levodopa cost effective versus levodopa-sparing therapy in early PD. PharmacoEcon Outcomes News 878, 15 (2021). https://doi.org/10.1007/s40274-021-7701-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-021-7701-4